State Of Wisconsin Investment Board Spectrum Pharmaceuticals Inc Transaction History

State Of Wisconsin Investment Board

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.27 - $2.42 $256,921 - $489,566	-202,300 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$3.38 - $5.14 $102,076 - $155,228	30,200 Added 17.55%	202,300 $690,000
Q3 2020 Nov 16, 2020	SELL	$2.99 - $4.9 $34,086 - $55,860	-11,400 Reduced 6.21%	172,100 $702,000
Q2 2020 Aug 12, 2020	BUY	$2.11 - $3.38 $24,054 - $38,532	11,400 Added 6.62%	183,500 $620,000
Q1 2020 May 06, 2020	BUY	$1.83 - $3.45 $8,967 - $16,905	4,900 Added 2.93%	172,100 $401,000
Q3 2019 Nov 12, 2019	BUY	$7.03 - $9.7 $167,314 - $230,859	23,800 Added 16.6%	167,200 $1.39 Million
Q2 2019 Aug 14, 2019	BUY	$7.36 - $11.26 $23,552 - $36,032	3,200 Added 2.28%	143,400 $1.24 Million
Q1 2019 May 13, 2019	BUY	$9.08 - $11.84 $328,696 - $428,608	36,200 Added 34.81%	140,200 $1.5 Million
Q4 2018 Feb 11, 2019	BUY	$6.39 - $16.99 $19,809 - $52,668	3,100 Added 3.07%	104,000 $910,000
Q2 2018 Aug 03, 2018	BUY	$14.31 - $21.75 $191,754 - $291,450	13,400 Added 15.31%	100,900 $2.12 Million
Q1 2018 May 07, 2018	BUY	$16.09 - $23.07 $474,655 - $680,565	29,500 Added 50.86%	87,500 $1.41 Million
Q3 2017 Nov 01, 2017	BUY	$8.75 - $14.07 $507,500 - $816,060	58,000	58,000 $816,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.